Crucially, both the expression of NGAL in the injured renal tubule and the concentration of NGAL in the urine increase in proportion to the severity of kidney injury,[12, 34, 35] thus providing biological plausibility for its use as an AKI biomarker. The gene discussed is LCN2; the disease is acute kidney injury.